NN, Inc.: Q2 Shows Progress, But I'm Staying On The Sidelines For Now

NN, Inc.'s (NNBR) Q2 2025 results presented a mixed outlook, demonstrating significant margin expansion and new business wins, particularly in the high-quality medical and electrical sectors. However, the precision manufacturer experienced revenue shortfalls driven by automotive weakness and cautious customer ordering. While the stock's valuation appears inexpensive on EV/sales and forward EV/EBITDA, concerns persist due to high leverage, negative growth trends, and execution risk.

Analysis

NN, Inc.'s (NNBR) Q2 2025 results present a bifurcated operational profile, characterized by both strategic progress and significant headwinds. The company is making demonstrable headway on improving profitability, evidenced by margin expansion, while simultaneously building a higher-quality revenue pipeline with new business wins in its medical and electrical segments. However, these positive developments are offset by top-line weakness, with revenues missing expectations due to persistent softness in the automotive sector and cautious customer ordering. While NNBR's valuation appears inexpensive based on forward EV/EBITDA and EV/sales metrics, this is counterbalanced by substantial risks, including high leverage, negative overall growth trends, and notable execution risk.

Key Decisions for Investors

• Investors should weigh the attractive valuation against significant fundamental risks, particularly the company's high leverage and negative top-line growth trends.
• Monitor the performance of the medical and electrical segments closely, as their ability to offset automotive weakness is critical to the investment thesis.
• Consider holding off on new positions until there are clear signs of stabilization in the automotive end-market or a material improvement in the company's revenue trajectory and debt profile.